heart failure

ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
JNJ
Invokana
diabetes
heart failure
Flag link:
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
CP Wire
BioCardia
CardiAMP
heart failure
clinical trials
Flag link:
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
BioCardia
CardiAMP
heart failure
Flag link:
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
Flag link:
Heart group warns of cardiovascular risks after treatment for breast cancer
Heart group warns of cardiovascular risks after treatment for breast cancer
Stat
breast cancer
heart failure
chemotherapy
heart disease
Flag link:
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
Fierce Pharma
Novartis
Entresto
drug launches
heart failure
oncology
Flag link:
After a slow start, Novartis finally gains market traction with heart drug Entresto
After a slow start, Novartis finally gains market traction with heart drug Entresto
Fierce Biotech
Novartis
Entresto
heart failure
Flag link:
Cytokinetics inches forward with heart failure program
Cytokinetics inches forward with heart failure program
BioPharma Dive
Cytokinetics
Omecamtiv Mecarbil
Amgen
heart failure
Japan
Flag link:
How Novartis Is Aiming to Increase Entresto Sales in 2017
How Novartis Is Aiming to Increase Entresto Sales in 2017
Market Realist
Novartis
Entresto
heart failure
Flag link:
What Could Boost Medicare Demand for Novartis’s Entresto?
What Could Boost Medicare Demand for Novartis’s Entresto?
Market Realist
Novartis
Entresto
Medicare
heart failure
Flag link:
Novartis Heart Failure Drug Beats Enalapril
Novartis Heart Failure Drug Beats Enalapril
Investopedia
Novartis
heart failure
Entresto
Enalapril
Flag link:
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Fierce Biotech
Renova Therapeutics
gene therapy
heart failure
Janssen
stresscopin
Flag link:
Novartis Social Media Network for Patients - Is This a Good Idea
Novartis Social Media Network for Patients - Is This a Good Idea
CP Wire
Novartis
social media
heart failure
Flag link:
Novartis Unveils Heart Failure Social Network
Novartis Unveils Heart Failure Social Network
Investopedia
Novartis
heart failure
social media
Flag link:
Study Suggests Some NSAIDs Associated With Increased Risk Of Heart Failure
Study Suggests Some NSAIDs Associated With Increased Risk Of Heart Failure
Xtalks
NSAIDs
heart failure
Flag link:
Novartis continues data push for Entresto
Novartis continues data push for Entresto
BioPharma Dive
Novartis
Entresto
heart failure
Flag link:
How to save 28,000 heart patients a year? Use Novartis' Entresto, JAMA says
How to save 28,000 heart patients a year? Use Novartis' Entresto, JAMA says
Fierce Pharma
JAMA
Novartis
Entresto
heart failure
Flag link:
Why Novartis' new heart med could reverse slow start
Why Novartis' new heart med could reverse slow start
BioPharma Dive
Novartis
Entresto
heart failure
Flag link:
Novartis, Amgen to See Higher Sales of New Heart Drugs
Novartis, Amgen to See Higher Sales of New Heart Drugs
Bidness, ETC
Novartis
Amgen
Entresto
Corlanor
heart failure
Flag link:
Novartis launches ambitious clinical program for Entresto
Novartis launches ambitious clinical program for Entresto
BioPharma Dive
Novartis
Entresto
clinical trials
heart failure
Flag link:

Pages